Used primarily in the management of chronic kidney disease associated with type 2 diabetes, this compound helps reduce the risk of kidney function decline and cardiovascular events. It acts as a non-steroidal mineralocorticoid receptor antagonist, offering organ protection by reducing inflammation and fibrosis in the heart and kidneys. Its selective action allows for effective treatment with a lower incidence of certain side effects compared to traditional therapies. Commonly prescribed in patients with albuminuria, it supports long-term renal and cardiovascular outcomes when used alongside standard care like antihypertensives and glucose-lowering agents.